Latest Period
Q1 2026
Security Snapshot
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) Institutional Ownership
CUSIP: 89455T109
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
114
Shares (Excl. Options)
35,922,131
Price
$1.34
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common stock, $0.001 par value
- Symbol
- TMCI on Nasdaq
- Shares outstanding
- 64,609,137
- Price per share
- $1.78
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 35,922,131
- Total reported value
- $48,144,671
- % of total 13F portfolios
- 0%
- Share change
- +2,282,714
- Value change
- -$3,585,758
- Number of holders
- 114
- Price from insider filings
- $1.78
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value is tracked under CUSIP 89455T109.
- 114 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 114 to 114 between Q4 2025 and Q1 2026.
- Reported value moved from $87,953,121 to $48,144,671.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 114 institutions filings for Q1 2026.
Investment Quick Answers
What is CUSIP 89455T109?
CUSIP 89455T109 identifies TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 89455T109:
Significant Owners of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.8% | -1.4% | $12,791,640 | 6,364,000 | 0% | Armistice Capital, LLC | 31 Mar 2026 | |
| GAGNON SECURITIES LLC | 9.6% | +55% | $15,355,268 | +$5,406,632 | 6,142,107 | +54% | Neil Gagnon | 31 Dec 2025 |
| BANK OF AMERICA CORP /DE/ | 5.5% | $7,102,886 | 3,533,774 | BANK OF AMERICA CORP /DE/ | 31 Mar 2026 | |||
| MORGAN STANLEY | 3.4% | $13,931,448 | 2,091,809 | Morgan Stanley | 31 Dec 2024 | |||
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.8% | -67% | $2,863,745 | -$6,297,435 | 1,145,498 | -69% | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 31 Dec 2025 |
As of 31 Mar 2026, 114 institutional investors reported holding 35,922,131 shares of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI). This represents 56% of the company’s total 64,609,137 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) together control 51% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.9% | 6,364,000 | 0% | 0.28% | $8,527,760 |
| GAGNON SECURITIES LLC | 8.1% | 5,201,886 | +67% | 1.6% | $6,970,527 |
| BlackRock, Inc. | 5.2% | 3,340,023 | -2.1% | 0% | $4,475,632 |
| BANK OF AMERICA CORP /DE/ | 5% | 3,214,293 | +39% | 0% | $4,307,153 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3% | 1,461,507 | 0% | 0% | $1,958,419 |
| STATE STREET CORP | 1.9% | 1,235,518 | +24% | 0% | $1,655,594 |
| CIBC Bancorp USA Inc. | 1.9% | 1,218,353 | 0% | $1,632,593 | |
| MILLENNIUM MANAGEMENT LLC | 1.8% | 1,148,115 | -24% | 0% | $1,538,474 |
| AQR CAPITAL MANAGEMENT LLC | 1.6% | 1,061,840 | 0% | $1,422,866 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 1,010,843 | -12% | 0% | $1,354,788 |
| ACADIAN ASSET MANAGEMENT LLC | 1.5% | 941,293 | +42% | 0% | $1,255,000 |
| D. E. Shaw & Co., Inc. | 1.3% | 841,269 | +34% | 0% | $1,127,300 |
| CITADEL ADVISORS LLC | 1.3% | 825,575 | +290% | 0% | $1,106,270 |
| WEBER CAPITAL MANAGEMENT LLC /ADV | 0.91% | 589,617 | 0% | 0.79% | $790,087 |
| UBS Group AG | 0.84% | 542,905 | +85% | 0% | $727,493 |
| RENAISSANCE TECHNOLOGIES LLC | 0.81% | 522,900 | 0% | $700,686 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.67% | 435,893 | 0% | 0% | $584,097 |
| NORTHERN TRUST CORP | 0.63% | 405,903 | +3.1% | 0% | $543,910 |
| GSA CAPITAL PARTNERS LLP | 0.62% | 398,007 | +14% | 0.03% | $533,000 |
| GOLDMAN SACHS GROUP INC | 0.6% | 387,685 | +105% | 0% | $519,498 |
| RAYMOND JAMES FINANCIAL INC | 0.55% | 357,556 | +11% | 0% | $479,125 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.51% | 328,839 | -6.7% | 0% | $440,644 |
| VANGUARD FIDUCIARY TRUST CO | 0.49% | 318,004 | 0% | 0% | $426,125 |
| XTX Topco Ltd | 0.44% | 285,780 | +289% | 0.01% | $382,945 |
| MARSHALL WACE, LLP | 0.41% | 264,933 | 0% | $355,010 |
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 35,922,131 | $48,144,671 | -$3,585,758 | $1.34 | 114 |
| 2025 Q4 | 35,847,129 | $87,953,121 | -$21,906,721 | $2.45 | 114 |
| 2025 Q3 | 38,823,239 | $260,292,697 | +$3,224,800 | $6.71 | 117 |
| 2025 Q2 | 38,411,285 | $225,932,843 | +$594,572 | $5.88 | 122 |
| 2025 Q1 | 37,892,233 | $314,933,438 | +$6,396,329 | $8.39 | 136 |
| 2024 Q4 | 37,307,543 | $277,767,394 | -$15,594,697 | $7.44 | 133 |
| 2024 Q3 | 39,629,299 | $229,799,434 | +$2,450,302 | $5.80 | 133 |
| 2024 Q2 | 39,705,068 | $264,072,594 | -$75,189,680 | $6.65 | 126 |
| 2024 Q1 | 41,245,049 | $537,228,351 | +$3,488,774 | $13.05 | 129 |
| 2023 Q4 | 41,010,068 | $522,886,552 | +$21,281,231 | $12.75 | 126 |
| 2023 Q3 | 39,193,648 | $513,809,790 | -$36,596,248 | $13.11 | 121 |
| 2023 Q2 | 38,926,750 | $995,556,262 | +$84,284,218 | $25.58 | 135 |
| 2023 Q1 | 35,535,142 | $895,139,591 | +$184,017,260 | $25.19 | 122 |
| 2022 Q4 | 26,874,663 | $617,852,430 | +$44,023,715 | $22.99 | 105 |
| 2022 Q3 | 26,104,333 | $576,118,458 | +$73,324,010 | $22.07 | 90 |
| 2022 Q2 | 23,108,213 | $331,376,313 | +$38,889,452 | $14.34 | 81 |
| 2022 Q1 | 20,370,513 | $385,285,843 | +$38,473,149 | $18.91 | 74 |
| 2021 Q4 | 17,228,093 | $320,930,460 | +$66,992,636 | $18.64 | 74 |
| 2021 Q3 | 13,036,758 | $350,676,095 | -$6,970,436 | $26.90 | 61 |
| 2021 Q2 | 13,009,799 | $406,683,468 | +$406,677,512 | $31.26 | 70 |
| 2021 Q1 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q4 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q3 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q2 | 179 | $6,000 | $33.52 | 1 | |
| 2020 Q1 | 179 | $6,000 | $33.52 | 1 | |
| 2019 Q4 | 179 | $6,000 | $33.52 | 1 | |
| 2019 Q3 | 179 | $6,000 | $33.52 | 1 | |
| 2019 Q2 | 179 | $6,000 | $33.52 | 1 | |
| 2019 Q1 | 179 | $6,000 | $33.52 | 1 |